Animas to Discontinue Manufacturing and Sale of Insulin Pumps


Animas Corporation has announced that it will discontinue the manufacturing and sale of Animas® Vibe® and OneTouch Ping® insulin pumps, close operations and exit the insulin pump business.

Animas has selected Medtronic as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers. Patients using an Animas insulin pump will be offered the option to transfer to a Medtronic pump.

Patient safety and continuity of care is of utmost importance and Animas will continue to provide customer service, training and warranty support, including providing pump supplies that are used in conjunction with the Animas® Vibe® and OneTouch Ping® insulin pumps, through a transition period.

“We recognize that patients living with diabetes rely on our products to provide critical care, and we want to reassure them that we will be with them every step of the way throughout this transition,” said Valerie Asbury, General Manager of Animas Corporation. “Our number one priority is ensuring patients have a seamless experience as they transition to Medtronic. For over 30 years, Medtronic has been a global leader in the treatment of those living with diabetes, and we are confident they will provide outstanding support to our patients and their healthcare teams.”

“We are incredibly grateful to our patients and healthcare partners for the trust, confidence and loyalty they have placed in Animas products over the last 12 years,” Asbury said. “With changing needs of customers, rapidly evolving market dynamics, and increased competitive pressures, it proved too difficult to sustain the insulin pump business and we decided to pursue an exit of the business. This decision was extremely difficult and comes following the extensive exploration of all other viable options for the Animas business.”

Approximately 90,000 patients currently use Animas pumps and products. Those patients, caregivers and healthcare providers may explore insulin pump transition options by visiting or contacting Medtronic at the following toll-free numbers:

Animas has discontinued the sale of all Animas® Vibe® and OneTouch Ping® insulin pumps in the U.S. and Canada, effective immediately. A decision and timing to exit countries outside of the U.S. and Canada is subject to completing consultation with relevant works councils. For the patients, caregivers and healthcare providers outside of the U.S. and Canada who currently use Animas pumps and products, Animas will continue to sell pumps and operate as usual.

Notify of
oldest most voted
Inline Feedbacks
View all comments
5 years ago

I am very upset to find that a company I have depended upon for the last 12 years is disappearing. I have needed the .25 basal adjustment and the Animas pump was the only one I could do this with —I have not checked other pumps to see what is currently available so perhaps this has changed. I have also needed to set a 00.00 basal for 4 hours a day, again, something I was not able to do with other pumps—in the past. After 67 years with diabetes I am still fine so I feel as though I am… Read more »

Damion Perrine
Damion Perrine
5 years ago
Reply to  Barbara

I,too, felt the same as you. I’ve been with Animas for 15 years. I’m currently looking at other options. The reason I replied, though, is that you have given me hope. I’ve had Juvenile Diabetes for 38 years, and to know that you have had diabetes for 67 years and you’re still going strong is inspirational to say the least. Good luck in your quest for a new pump supplier and God bless you, as he’s been doing now for so many years.

Copyright © 2009-2021 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.
Would love your thoughts, please comment.x